Verizon has stepped onto the launch-pad! Let's GO!I posted about this setup last week, and so far it has played out exactly as I described. I wanted to give a little update based on todays price action. I will keep this short as I have provided the key points on the chart. But this is the 5-minute chart from todays session.
The stock appears to have stepped right onto the launch-pad and has put some major Option Strikes within striking distance before the week is out.
Tech stocks appear to be stepping back a bit (they were on average very overbought), and TLT (20 year treasury ETF) has staged a quiet rally in recent weeks.
I think there is some major strength appearing in the bond market, despite the US tax bill, I think yields will ultimately trend down, and defensives (especially VZ) will perform well. I have upgraded my 2025 target from $47.50 to $53 after digging through the numbers a bit more, and after considering more potential rate cuts later this year.
This will be VZ's 2nd test of the long-term bull-flag resistance, and it appears a breakout may be imminent. If the daily chart shows high volume and closes above that level this week, I think we're off to the races. Ignore this setup at your own peril :) I think it's a great opportunity, and regardless of what happens, this is a great stock to hold long-term. Currently paying a whopping 6.1%+ dividend.
A great addition for any dividend portfolio even at $53 (some analysts project higher, but I personally believe it may not go beyond that point until 2026 unless markets deteriorate or there is some other black swan event in 2025).
Good luck! Let me know if you have any questions. Cheers!
Community ideas
Verizon to the Moon? - Click my Post on the 15-minute Chart!TradingView doesn't show a link to my 15-minute chart analysis from today on the daily timeframe, but you can find a comprehensive analysis in my profile.
I just wanted to add an idea here so people would be able to find it on this time-frame.
Either switch to 15-minute, or check my profile to get the full scoop!
Cheers!
EMA SystemThe system of Moving Averages I started out using is the 9-21-50 SMA. I would use the Fast EMA as a trailing stop loss and only trade long when it's above the 50 SMA. The 21 SMA is often a zone where price can bounce back.
12-21 EMA—EMA of EMA can work as well. So can 50-200 SMA or EMA of EMA for telling the larger trend if you want to enter an Option, then trading against it can be fatal.
10 Small-Cap Biotechs with Key Catalysts for 2025 July List________________________________________
🔬 10 Small-Cap Biotechs with Key Catalysts for 2025 July List
________________________________________
1. Allogene Therapeutics (NASDAQ: ALLO)
• Catalyst: Phase 2 data for ALLO-501A (anti-CD19 CAR-T for large B-cell lymphoma) expected in H2 2025; potential pivotal data could lead to regulatory submission.
• Highlights: “Off-the-shelf” allogeneic CAR-T approach could transform cell therapy; watch for manufacturing/scalability updates.
________________________________________
2. Lixte Biotechnology (NASDAQ: LIXT)
• Catalyst: Phase 2 combo trial of LB-100 (PP2A inhibitor) + immunotherapy in solid tumors, with key data expected in late 2025.
• Highlights: If efficacy signals emerge, could prompt partnerships or additional trials.
________________________________________
3. Iovance Biotherapeutics (NASDAQ: IOVA)
• Catalyst: Commercial launch and sales uptake for AMTAGVI (lifileucel, first FDA-approved TIL therapy in advanced melanoma); upcoming label expansion studies in lung and cervical cancer.
• Highlights: Investor focus on launch ramp, real-world data, and new trial initiations in 2025.
________________________________________
4. RenBio (NASDAQ: RENB)
• Catalyst: Phase 1/2 data for RB-100 (bispecific antibody platform in solid tumors) expected mid-to-late 2025.
• Highlights: Pipeline progress and partnership announcements possible.
________________________________________
5. IGM Biosciences (NASDAQ: IGMS)
• Catalyst: Phase 2 data for IGM-2323 (CD20 x CD3 bispecific in non-Hodgkin lymphoma) expected early 2025; ongoing updates from IgM antibody platform.
• Highlights: Investor interest in clinical safety, efficacy, and potential for big pharma tie-ups.
________________________________________
6. Zura Bio (NASDAQ: ZURA)
• Catalyst: Phase 2b/3 trial start and topline data for tibulizumab (IL-7Ra mAb for autoimmune diseases) expected late 2025.
• Highlights: Focus on rare and orphan autoimmune indications.
________________________________________
7. INmune Bio (NASDAQ: INMB)
• Catalyst: Phase 2 Alzheimer’s data (XPro1595, targeting neuroinflammation) and oncology pipeline updates expected H1 2025.
• Highlights: Any signal in Alzheimer’s is high-impact; monitoring for FDA guidance.
________________________________________
8. Veru Inc (NASDAQ: VERU)
• Catalyst: Phase 3 trial results for enobosarm (oral SARM) in advanced breast cancer expected 2025; also, COVID/sepsis drug updates.
• Highlights: Regulatory clarity and partnership/M&A rumors are potential drivers.
________________________________________
9. Century Therapeutics (NASDAQ: IPSC)
• Catalyst: First-in-human data for iPSC-derived NK and CAR-T cell therapies, with updates expected at major meetings in 2025.
• Highlights: Platform validation and early efficacy/safety signals.
________________________________________
10. ProKidney (NASDAQ: PROK)
• Catalyst: Phase 3 pivotal data for REACT (cell therapy for chronic kidney disease/diabetes) due late 2025.
• Highlights: If positive, could become the first autologous cell therapy for kidney disease.
________________________________________
🔎 How to Monitor These Catalysts
• FDA submissions/meetings (ALLO, PROK, VERU)
• Clinical trial readouts (LIXT, RENB, IGMS, ZURA, INMB, IPSC)
• Commercial/launch data (IOVA)
• Partnership/M&A activity (IGMS, VERU, RENB)
________________________________________
📊 Summary Table
Ticker Company Upcoming Catalyst/Event Timeframe
ALLO Allogene Therapeutics Phase 2 LBCL CAR-T pivotal data H2 2025
LIXT Lixte Biotechnology LB-100 + immunotherapy Phase 2 data Late 2025
IOVA Iovance Biotherapeutics AMTAGVI launch data; label expansions Throughout 2025
RENB RenBio Bispecifics Phase 1/2 data Mid-to-late 2025
IGMS IGM Biosciences IGM-2323 Phase 2 data (lymphoma) Early 2025
ZURA Zura Bio Tibulizumab Phase 2b/3 topline data Late 2025
INMB INmune Bio Alzheimer’s/oncology trial updates H1 2025
VERU Veru Inc Enobosarm Phase 3 (breast cancer) 2025
IPSC Century Therapeutics First-in-human iPSC cell therapy data 2025
PROK ProKidney REACT Phase 3 (CKD) pivotal readout Late 2025
________________________________________
⚠️ Word of Caution
Small-cap biotech stocks can be extremely volatile, especially around catalyst events (trial data, FDA decisions). Sharp price swings—both up and down—are common. Always conduct your own research and be aware of the risks.
$NVDA: Levitating higher: Next Stop 175$: 250$ Before cycle endsIn this summer bull market, it makes more sense to talk about the large cap winners. NASDAQ:NVDA chart is a beauty to watch with the steady climb of this mega cap stock levitates all the indices including S&P500 and NASDAQ. After hitting 90$ during the Liberation Day drawdown the stock is 60% up since then and recovered all its losses and hitting a new ATH. With stock at 158 $ it is targeting the highs of the upward sloping Fib Retracement channel which indicates that stock can reach a price of 175$ before this run loses its steam. At RSI of 65 this is not overbought compared to its historical level of 84. Hence there might be more room left in this bull run for $NVDA. My prediction is that before end of July 2025 the stock hits 175$.
But where do we like to see this outperforming stock during this cycle of bull run. Will it hit 5T USD before Dec 2024? If NASDAQ:NVDA hits 5T USD, then the stock will be 205 $ which in my opinion not impossible before Dec 2025. 40% Upside in the Market Cap and the stock price is achievable in a momentum stock like $NVDA.
Verdict: NASDAQ:NVDA @ 175 $ before July 2025 & 205 $ or 5 T USD Market Cap before Dec 2025
ATAI | High Risk/RewardATAI Life Sciences operates in the emerging psychedelic medicine sector, developing novel treatments for mental health disorders including depression, anxiety, and addiction. The company focuses on therapeutic applications of compounds like psilocybin and MDMA.
Technical Analysis:
The weekly chart reveals a compelling setup after an extended consolidation period around the $2.60 support zone.
Key observations:
• Long Base Formation: Price has held above critical support for over 18 months, building a solid foundation
• Breakout Potential: Recent price action shows signs of life above the consolidation range
• High Risk/Reward Setup: The path (pink arrow) shows massive upside potential targeting $10+ levels
Trade Setup:
• Entry Zone: Current levels around $2.60-$2.80
• Stop Loss: Below $2.00 (invalidation of base)
• Target: Initial target $6.00, extended target $10.00+
• Risk/Reward: Exceptional 4:1+ ratio
Short-term opportunities are imminent.Gold prices have continued to rebound recently and have reached around 3358, but there is a lack of effective retracement during the rise, and the risk of short-term chasing has increased significantly. From a technical perspective, the US dollar index has a demand for a corrective rebound after a rapid decline, and it is expected to form a significant suppression on gold in the short term, limiting the rebound space of gold prices. From a capital perspective, the previous high-level long chips have gradually been untied and started to leave the market with profits, and selling pressure has gradually emerged; short positions may be re-arranged after completing concentrated stop losses, and the market structure is quietly changing.
Based on the above factors, it is recommended that traders remain patient and continue to hold short positions, focusing on the support of the 3335-3325 area. Be sure to control your position during the operation, strictly set stop losses, and avoid the high risks brought by chasing the rise. The core of trading is to follow the trend, respect the market rhythm, and wait for the adjustment to be confirmed before intervening.
Steady trading can only make long-term profits. Welcome everyone to share and communicate to improve the operation level together.
Falling towards 50% Fibonacci support?The Loonie (USD/CAD) is falling towards, the pivot which acts as a pullback support and could bounce to the 61.8% Fibonacci resistance.
Pivot: 1.3623
1st Support: 1.3579
1st Resistance: 1.3695
Risk Warning:
Trading Forex and CFDs carries a high level of risk to your capital and you should only trade with money you can afford to lose. Trading Forex and CFDs may not be suitable for all investors, so please ensure that you fully understand the risks involved and seek independent advice if necessary.
Disclaimer:
The above opinions given constitute general market commentary, and do not constitute the opinion or advice of IC Markets or any form of personal or investment advice.
Any opinions, news, research, analyses, prices, other information, or links to third-party sites contained on this website are provided on an "as-is" basis, are intended only to be informative, is not an advice nor a recommendation, nor research, or a record of our trading prices, or an offer of, or solicitation for a transaction in any financial instrument and thus should not be treated as such. The information provided does not involve any specific investment objectives, financial situation and needs of any specific person who may receive it. Please be aware, that past performance is not a reliable indicator of future performance and/or results. Past Performance or Forward-looking scenarios based upon the reasonable beliefs of the third-party provider are not a guarantee of future performance. Actual results may differ materially from those anticipated in forward-looking or past performance statements. IC Markets makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or any information supplied by any third-party.
Pyth Big long to $0.1155Just recently opened a long trade on pyth. Aiming for $0.1116 to $0.1155
Beautiful setup.
Market is bullish and seems the correction have come to an end on the 1hr tf. Anticipating strong push soon.
Not much to be said here, the price action is clean and the idea is clear, trade with the trend.
Whales are also loading up.
DTT setup
#BTC enters resistance zone, beware of pullback📊#BTC enters resistance zone, beware of pullback⚠️
🧠From a structural perspective, the target of this rise has been achieved, so we need to be wary of a mid-term correction.
➡️From a graphic perspective, the daily level seems to be forming a bull flag. This is the third time we are close to the upper edge of the flag. I think the probability of encountering resistance and falling back is higher than the probability of continuing to break through.
Let's see👀
🤜If you like my analysis, please like💖 and share💬
BITGET:BTCUSDT.P
LVMH BUYLVMH is trading at around €468, well below its 2023 highs and at a significant discount to historical valuation multiples. The forward P/E is approximately 17x, versus a 5-year average of 24x. EV/EBITDA is under 10x, and the dividend yield is near 3%.
Fundamentals remain strong. LVMH continues to generate high free cash flow, maintains operating margins above 25%, and has one of the most powerful brand portfolios in the world. Weakness in Wines & Spirits and soft consumer demand in China have driven the stock lower, but long-term structural growth remains intact.
Recent developments include a 10-year partnership with Formula 1 through Glenmorangie, new retail leadership at Rimowa, and expansion of flagship stores in Asia focused on experience. These signal continued strategic positioning, not retreat.
With fair value estimates in the €550–600 range, LVMH currently offers 17–28% upside. A staged buy strategy between €455–470 appears well-supported. Short-term traders may use €430 as a technical stop.
LVMH offers long-term quality at a temporary discount.
Tesla: Back on Track?Tesla has resumed downward momentum, aligning with our primary scenario and moving away from resistance at $373.04. As part of the ongoing turquoise wave 5, we expect continued selling pressure: it should break below the $215.01 support. This would complete magenta wave (3) of the current bearish impulse. A reversal back above $373.04 – and especially a breach of $405.54 – would force us to adopt the 38% likely alternative scenario. Under this count, the correction low of blue wave alt.(II) would be already in, and Tesla would now be rallying in wave alt.(III) .
📈 Over 190 precise analyses, clear entry points, and defined Target Zones - that's what we do.
$SOUN Breakout Setup – Clean Bullish Structure with Strong R/RSoundHound AI ( NASDAQ:SOUN ) is showing a strong technical setup as it pushes above the Ichimoku cloud on the daily chart. Price has been consolidating for over a month in a tight range between $9 and $10.30. Today’s breakout above the cloud with bullish MACD crossover signals potential trend continuation.
Key technicals:
Ichimoku Cloud: Price has closed above the Kumo with Tenkan-sen crossing above Kijun-sen—classic bullish signal.
MACD: Fresh bullish crossover with histogram flipping positive for the first time since mid-May.
Volume: Volume has been increasing on up days, suggesting accumulation.
Trade setup:
Entry: $10.30 (breakout candle)
Stop: $9.05 (below recent consolidation base and cloud)
Target: $13.41 (prior high and R1 pivot level)
Risk/Reward: 2.41
If price holds above $10 and consolidates, it could offer a low-risk add or re-entry zone. Momentum traders may wait for confirmation above $10.55 with volume before committing.
This setup offers both breakout potential and clean invalidation, making it attractive for swing traders and breakout traders alike.
Gold retreats as expected, how to trade in the future📰 News information:
1. Geopolitical situation
2. PMI data
3. Global Central Bank Governors Meeting
📈 Technical Analysis:
Our short orders have achieved profits. I closed the position near 3337, turning losses into profits. Interested friends can follow my previous post. In the short term, I am still optimistic that gold will retreat below 3335-3325. Today, gold rose sharply, and the rebound momentum was strong, while the short-term correction was slightly weak, so the space for a second decline in the short term will be limited. If it falls to the 3333-3323 range during the day and gets effective support, you can consider going long. The short-term upper resistance is 3360-3375.
🎯 Trading Points:
BUY 3333-3323-3315
TP 3341-3355-3360-3375
In addition to investment, life also includes poetry, distant places, and Allen. Facing the market is actually facing yourself, correcting your shortcomings, confronting your mistakes, and strictly disciplining yourself. I hope my analysis can help you🌐.
TVC:GOLD OANDA:XAUUSD FX:XAUUSD FOREXCOM:XAUUSD PEPPERSTONE:XAUUSD FXOPEN:XAUUSD
AMZN Is Coiling Up for a Gamma Push — Don’t Sleep on This Zone🔍 GEX Outlook & Option Bias:
Amazon (AMZN) is sitting right at the heart of a bullish Gamma setup. The 220–225 zone is where the action is:
* Highest Net Positive GEX sits at 225 — major gamma magnet and potential squeeze target.
* 49.56% Call Wall at 222.5 confirms call-dominant sentiment.
* IVR at 27.4 and IVX avg 32.9 show room for expansion.
* Call dollar flow is 58%, signaling buyers are still active.
📌 GEX Implication: Price above 217.5 opens door for a push into 222.5 → 225. This is a clean Call Entry Zone for 0DTE or 2DTE scalpers looking for quick momentum moves into gamma walls.
📈 TradingView Chart Analysis (1H):
From the second chart:
* AMZN broke bullish structure last week and is now consolidating after the CHoCH near 218.
* The price is respecting the uptrend channel and sitting just above the midline support.
* Volume is steady and bullish OBs below offer strong bounce potential.
🟢 Trading Idea:
Call Setup (if price stays above 219.4):
* 🎯 Entry: 220–221
* 🎯 Target: 222.5 → 225
* 🛑 Stop: 217.5 (below bullish OB & PUT support)
Put Setup (if price loses 217.5 with volume spike):
* 🚨 Entry: below 217.5
* 🚨 Target: 216.7 → 212
* 🛑 Stop: 220.3
🎯 Bias & Final Thought:
Market wants to test 222.5 and possibly gamma squeeze to 225 if buyers step up. If it fails to hold 219.4, fade it down into the lower OB zone around 212.
Watch volume at support — low volume means a trap; high volume confirms real move.
Disclaimer: This content is for educational purposes only and not financial advice. Trade at your own risk.
Gold bulls V-shaped reversal, price is rushing to 3350Gold trend analysis: Geopolitical risks still exist, technical side is strong and volatile
The recent situation in the Middle East presents a cycle of "conflict-easing-re-escalation". After a brief exchange of fire between Iran and Israel, Israel turned to attacking surrounding armed forces, and geopolitical risks have not completely dissipated. Such "deterrent conflicts" may recur, and the support effect of risk aversion on gold will ferment intermittently. The market needs to be alert to sudden events that drive the price of gold to rise in a pulsed manner.
4-hour cycle
Indicator signal: Stochastic indicator golden cross, MACD double lines sticking upward, showing the accumulation of bullish momentum.
Key pressure: 3340 (upper rail of the descending channel), breaking through will open up the upward space.
Short-term support: 3295 (yesterday's top and bottom conversion position), if lost, it will turn to oscillation.
Hourly line pattern
Short-term moving averages are arranged in a bullish pattern, the low point of the callback gradually moves up, and the structure is strong.
【Operation strategy】
Main idea: Focus on low-long positions when the market is pulled back, and try to go short with a light position at the pressure level of 3340-3350.
Long order: enter the market at 3300-3305, target 3315-3320, stop loss 3292.
【Risk warning】
If the geopolitical conflict intensifies again, the gold price may quickly break through 3340, and the strategy needs to be adjusted in time.
During the US trading session, pay attention to the impact of US economic data on the US dollar.
HOOK/USDT – Bullish BreakoutHOOK has successfully broken out of a long-term descending trendline on the 4H chart, signaling a potential trend reversal to the upside. The breakout is backed by strong volume and price action above key resistance.
Analysis:
After weeks of lower highs, HOOK has flipped the structure by breaking the trendline and reclaiming horizontal resistance.
Price is now holding firmly above the breakout level, indicating bullish strength.
Key Levels to Watch:
Support Zones:
$0.1063 – Retest of trendline breakout (ideal entry zone)
$0.0996 – Previous structure base and strong horizontal support
Stoploss:
Below $0.0990 (invalidate breakout setup)
Resistance/Targets:
$0.1234 – First upside target (short-term)
$0.1508 – Major horizontal resistance from May
$0.1796 – Final upside target if momentum continues
Strategy:
As long as price holds above $0.1063, bias remains bullish. A healthy pullback toward support may provide a better entry opportunity for those waiting on confirmation.
Breakout traders may ride the momentum up to $0.1234+
DYOR | Not Financial Advice
The Big Beautiful RXTWith the bill passing and TA indicators popping up. I see these long term channels starting to break and the entire price action start to flip to the other side.
Watch the break and retest, especially if we see a spike in volume soon.
Really hard to lose long term with this one.
Nvidia - More Upside After Correction NVIDIA completed an irregular flat correction back in April. Since then, the price action has been strong and steady, forming higher highs and higher swing lows —a clear sign of bullish con-
continuation.
From an Elliott Wave perspective, the current move appears incomplete, as we cannot yet identify a full five five-wave advance from the April lows. This suggests that more upside may still be ahead.
However, we could see a wave four pullback develop sometime during the summer. If that occurs, the key support zone to watch would be around $140 down to $130, which could provide
an opportunity within the ongoing uptrend.
- Resistance: 170
- Support: 143 / 132
- Invalidation: 115
GH